GlucoFriend-evaluation the Effectiveness of Glucobay When Combined With a Basal Insulin

Combined Use of a Basal Insulin and Glucobay For Reducing PPG to End Diabetes Progress

To evaluate the effectiveness of Glucobay when combined with a basal insulin under daily-life treatment conditions in a large sample of Korean patients.

Inclusion Criteria:

• Signed written informed consent
• Age ≥ 18 years
• Diagnosed of type 2 diabetes for at least 6 months prior to enrollment
• Patients treated with stable dose of a basal insulin (insulin glargine or insulin detemir) at least 2 months
• HbA1C≥7.5 and ≤10.0%

Exclusion Criteria:

• Exclusion criteria must be read in conjunction with the local product information